In the highly regulated world of pharmaceutical development, success depends not only on innovation—but on the ability to navigate complex legal frameworks, ensure safety, and manage risk across the product lifecycle. That’s the focus of Module 5: Regulatory Affairs, Drug Safety and Pharmacovigilance from the GMDP Academy.
Running from June 30 to August 10, 2025, this six-week course is essential for professionals who need to understand how to bring medicines to market while meeting the highest standards of compliance, ethics, and global oversight.
Why This Knowledge Matters
Whether you’re overseeing submissions, tracking safety signals, or working across regulatory agencies, your ability to interpret and implement guidance from the U.S. FDA, EMA, and other global regulators is mission-critical.
Module 5 provides the regulatory fluency and pharmacovigilance grounding that life sciences professionals need to contribute effectively and lead confidently.
What You’ll Learn in Module 5
- The global regulatory landscape, including specialized procedures and international harmonization (ICH)
- The lifecycle approach to safety and risk management, from pre-approval to post-marketing
- Comparative frameworks for drug and device regulation
- Adverse event reporting, periodic safety updates, and risk evaluation strategies
- How to develop a global regulatory strategy aligned with patient safety and business objectives
Who Should Enroll?
This module is ideal for:
- Regulatory affairs professionals and safety officers
- Clinical development managers and medical directors
- Medical Affairs professionals who interface with regulatory teams
Format and Features
- Length: 6 weeks
- Dates: June 30 to August 10, 2025
- Format: Online, with asynchronous content and live expert webinars
- Effort: 5–12 hours/week
- Tuition: $2,500 USD
📎 Learn more: https://gmdpacademy.org/certification-programs/regulatory-affairs-drug-safety-pharmacovigilance/
✍️ Apply now: https://info.gmdpacademy.org/gmdpapplication
Build the Skills That Keep Medicines Safe
In an industry where public trust, regulatory approval, and patient outcomes intersect, Module 5 prepares you to be a guardian of quality and safety in medicines development.
Disclaimers
- The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred